
AC Immune
Price & Volume
Stats
See moreOpen | $2.08 |
Previous Close | $2.09 |
Day Range | $2.03-$2.13 |
52W Range | $2.01-$3.90 |
Market Cap | $211.7M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $19.8M |
Revenue Growth (YoY) | 245.5% |
Gross Profit (12 Mos) | -$22.8M |
Diluted EPS | -$0.44 |
News
See moreYahoo Finance • 2 months ago
Vertex Posts Positive Phase II Data on Kidney Disease Drug
Yahoo Finance • 2 months ago
AstraZeneca's Trixeo Secures Approval for Asthma in the EU
Yahoo Finance • 2 months ago
AbbVie's Rinvoq Wins EU Approval in Juvenile Idiopathic Arthritis
Yahoo Finance • 2 months ago
Novo's CagriSema Outshines Zepbound in Key Phase III Weight-Loss Study
About
CEO | Dr. Martin Zugel M.D., Ph.D. |
CFO | Mr. Christopher Roberts |
Address | Building B, Lausanne, Switzerland, 1015 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 90 |